Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 71-76

  Hernandez, Alicia ^a   Barberi, Laura ^a   Ballerio, Rossana ^a   Testini, Alessandra ^a   Ferioli, Roberto ^a   Bolla, Manlio ^a   Natali, Malvina ^a   Folco, Giancarlo ^a   Catapano, Alberico L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Centro Per Lo Studio   (Italy)

Author keywords

Acetylcholine; Aorta; Nitric oxide; Plasma cholesterol

Indexed keywords

CAPTOPRIL; DELAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; DOSE RESPONSE; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; VASODILATATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; ARTERIOSCLEROSIS; BODY WEIGHT; CAPTOPRIL; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; DATA INTERPRETATION, STATISTICAL; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; INDANS; MALE; NITRIC OXIDE; NITROGLYCERIN; NOREPINEPHRINE; RABBITS; TRIGLYCERIDES; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0032478225     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00254-2     Document Type: Article

References (38)

1. Dzau VJ. Tissue renin-angiotensin system: physiologic and pharmacological implications. Circulation. 77 (Suppl I):1988;1.
2. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor a-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1419.
3. Temizer DH, Yoshizumi M, Perrella MA, Susanni EE, Quertermous T, Lee ME. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotenisn II in rat aortic smooth muscle cells. J Biol Chem. 267:1992;24892.
4. Materson BJ, Preston RA. Angiotensin converting enzyme inhibitors in hypertension. A dozen years of experience. Arch Intern Med. 154:1994;513.
5. Burris JF. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. J Clin Pharmacol. 35:1995;337.
6. Geisterfer A, Peach M, Owens M. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988; 62:749.
7. Timmermans PB, Smith RD. Angiotensin II receptors subtypes: selective antagonists and functional correlates. Eur Heart J. 15:1994;79.
8. Griffin SA, Brown WBC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 17:1991;626.
9. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells. Role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest. 96:1995;141.
10. Katoh H, Suzuki H, Gata Y. Angiotensin-II stimulates collagen and biosynthesis fibronectin synthesis in cultured vascular smooth muscle cells. Clin Exp Hypertens (A). 12:1990;675.
11. Wolf G, Haberstroh U, Neilson EG. Angiotensin-II stimulates the proliferation and biosynthesis of type-I collagen in cultured murine mesangial cells. Am J Pathol. 140:1992;95.
12. Chopra M, Beswick H, Claperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and non-sulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol. 19:1992;330.
13. Ambrosioni E, Bacchelli S, Degli Espositi D, Borghi C. ACE-inhibitors and atherosclerosis. Eur J Epidemiol. 8(Suppl 1):1992;129.
14. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of Captopril in the Watanabe Heritable hyperlipidemic rabbit. Hypertension. 15:1990;327.
15. Chobanian AV, Haudenschild CC, Nickerson C, Hope S. Trandolapril inhibits atherosclerosis in the Watanabe Heritable Hyperlipidemic rabbit. Hypertension. 20:1992;473.
16. Hayek T, Keidar S, Ma-Yi Yi, Oiknine J, Breslow J. Effect of angiotensin converting enzyme inhibitors on LDL lipid peroxidation and atherosclerosis progression in E deficient mice. Circulation. 92:1995;1-625(Abs).
17. Aberg G, Ferrer P. Effects of Captopril on atherosclerosis in Cynomolgus monkeys. J Cardiovasc Pharmacol. 15((Suppl. 5)):1990;65.
18. Kowala MC, Grove RI, Aberg G. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and blood lipids. Atherosclerosis. 108:1994;61.
19. Becker RHA, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol. 18(suppl 2):1991;110.
20. Charpiot P, Rolland PH, Friggi A et al. ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arterioscler Thromb. 13:1993;1125.
21. Riezebos J, Vleeming W, Beems RB, van Amsterdam JGC, Meijer GW, de Wilt DJ, Porsius AJ, Wemer J. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction. J Cardiovasc Pharmacol. 23:1994;415.
22. Overturf ML, Sybers HD, Smith SA. Captopril-induced hyperreninemia in cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol. 47:1985;229.
23. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186.
24. Kowala MC. Captopril decreases accelerated atherosclerosis in hypertensive one kidney one clip rats feed cholesterol. Drug Dev Res. 29:1993;100.
25. Razzetti R, Acerbi D. Pharmacokinetics and pharmacologic properties of Delapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor. Am J Cardiol. 75:1995;7F.
26. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxigen acceptor. Ann Clin Biochem. 6:1969;24.
27. Catapano AL, Maggi FM, Cicerano V. The antiatherosclerotic effect of anipamil in cholesterol-fed rabbits. Ann New York Acad Sci. 522:1988;519.
28. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 226:1957;497.
29. Kiowski W, Linder L, Kleinbloesem C, Van Brummelen P, Bühler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects. Circulation. 85:1992;1.
30. Mene P, Fais S, Cinotti GA, Pugliese F, Luttmann W, Thierauch KH. Regulation of U-937 monocyte adhesion to cultured human mesangial cells by cytokines and vasoactive agents. Nephrol Dial Transplant. 10:1995;481.
31. Drexler H, Kurz S, Jeserich M, Münzel T, Hornig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol. 76:1995;13E.
32. Rubanyni GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 250:1986;822.
33. Krause S, Pohl A, Pohl C, Liebrenz A, Rühling K, Lösche W. Increased generation of reactive oxygen species in mononuclear blood cells from hypercholesterolemic patients. Thromb Res. 71:1993;237.
34. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785.
35. Luscher TF. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. Blood Press Suppl. 1:1994;18.
36. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248.
37. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 81:1990;482.
38. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546.